Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Quantum Biopharma ( (TSE:QNTM) ) just unveiled an update.
On June 27, 2025, Quantum BioPharma announced a non-brokered private placement of class A multiple voting shares, aiming to raise up to $600. The offering is expected to be fully subscribed by existing holders, including related parties, and the proceeds will be used for general working capital. This move is part of the company’s strategic efforts to strengthen its financial position and support its ongoing projects, potentially impacting its market presence and stakeholder interests.
More about Quantum Biopharma
Quantum BioPharma Ltd. is a biopharmaceutical company focused on developing innovative assets and biotech solutions for treating neurodegenerative and metabolic disorders, as well as alcohol misuse disorders. The company is engaged in research and development through its subsidiary, Lucid Psycheceuticals Inc., and has a strategic investment portfolio through FSD Strategic Investments Inc.
Average Trading Volume: 9,023
Technical Sentiment Signal: Hold
Current Market Cap: C$95.95M
See more data about QNTM stock on TipRanks’ Stock Analysis page.